Clinical Trials | October 27, 2022
Camizestrant significantly improved PFS vs. Faslodex in SERENA-2 Phase II trial
Results reinforce commitment to next-generation oral SERD development programme
Results reinforce commitment to next-generation oral SERD development programme
Oncodesign Services (ODS ), with 600 clients in 33 countries and 227 employees worldwide, provides services from target identification to hit-to-lead and lead optimization through to IND filing.
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
He is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
This recognition marks the third time in five years that Merck has been included on Fortune’s Change the World list.
The Coalition for Epidemic Preparedness Innovations (CEPI) has recently partnered with the consortium of India-based Bharat Biotech, University of Sydney and ExcellGene to develop “variantproof” COVID-19 vaccine.
Ours is a story of India’s resilient public health system and of everyone working together as team India to battle the pandemic
This inspection continues a series of successful inspections by Swissmedic in Vionnaz with the first inspection in 2015 followed by 2016, 2017 and 2020.
Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
